Drones to the rescue: flying HIV meds to Uganda's islands

NCT ID NCT06678022

Recruiting now Disease control Sponsor: Makerere University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using drones to deliver HIV medication to people living in remote islands of Uganda can improve viral suppression. Over 1,000 participants will either get their medication via drone or through standard methods. Researchers will compare viral load and retention in care over 24 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: antiretroviral therapy (ART) delivered by drone
What this could lead to: If successful, drone delivery could make it easier for people in remote areas to get their HIV medication regularly, leading to better health outcomes.
What could go wrong: This is a single trial in one district, so results may not apply elsewhere. Drones may face technical or weather issues, and the study relies on participants staying for 2 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV VIRAL LOAD

Contacts and locations

Locations

Bwendero Health Centre
RECRUITING

Kalangala, Ssese, Uganda
Mugoye health Centre III
RECRUITING

Kalangala, Ssese, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.